CorMedix (CRMD) Capital Expenditures (2010 - 2025)

CorMedix (CRMD) has 12 years of Capital Expenditures data on file, last reported at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures rose 16865.22% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 1848.28% YoY), and the FY2025 full-year result was $2.3 million, up 1848.28% from the prior year.
• Capital Expenditures climbed to $1.7 million in Q4 2025, from $505774.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q4 2025 to a low of $4324.0 in Q1 2022.
• A 5-year average of $217399.4 and a median of $19355.5 in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures tumbled 96.57% in 2024 and surged 16865.22% in 2025, its largest moves.
• Tracing CRMD's Capital Expenditures over 5 years: stood at $628761.0 in 2021, then plunged by 79.52% to $128755.0 in 2022, then soared by 129.84% to $295931.0 in 2023, then plunged by 96.57% to $10139.0 in 2024, then surged by 16865.22% to $1.7 million in 2025.
• Business Quant data shows CRMD's Capital Expenditures at $1.7 million in Q4 2025, $505774.0 in Q3 2025, and $23945.0 in Q2 2025.